Fig. 1 · Structure

Documents & Downloads

CBP-1018

PDC

CBP-1018 is a peptide-drug conjugate (PDC) designed to target FLOR1 and prostate-specific membrane antigen (PSMA) for enhanced tumor specificity. By conjugating Monomethyl auristatin E to a dual-targeting ligand through a specialized linker, CBP-1018 exhibits potent cytotoxicity against target cells. This compound is valuable for research applications focused on solid tumors and metastatic castration-resistant prostate cancer, facilitating studies aimed at developing targeted chemotherapy strategies.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Ligand / Binder
CAS Number 2923068-30-6
Applications PDC
Formula C132H192N30O38S
Molecular Weight 2839.18
SMILES
[C@H]([C@H](C(N[C@@H]([C@@H](O)C1=CC=CC=C1)C)=O)C)(OC)[C@]2(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(C(OCC3=CC=C(NC([C@@H](NC([C@@H](NC(CCCCCN4C(=O)C(SC[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CC5=CC=C(CNC(NCCCC[C@H](NC(N[C@@H](CCC(O)=O)C(O)=O)=O)C(O)=O)=O)C=C5)=O)CC(O)=O)=O)CC(O)=O)=O)CCCCN)=O)C(N[C@@H](CCCCNC(CC[C@H](NC(=O)C6=CC=C(NCC=7N=C8C(NC7)=NC(N)=NC8=O)C=C6)C(O)=O)=O)C(N)=O)=O)CC4=O)=O)[C@@H](C)C)=O)CCCNC(N)=O)=O)C=C3)=O)C)[C@H](C)C)=O)C(C)C)=O)C)[C@H](CC)C)OC)=O)CCC2)[H]

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...